CTSB and schistosomiasis: Recently, our collaborators have demonstrated the inbuilt adjuvant properties of Sm-cathepsin B. Immunizations with unadjuvanted Sm-cathepsin B could decrease both worm and hepatic egg burdens in a mouse model of schistosomiasis by 66 % and 51 %, respectively, when compared to saline control mice [30].